Search

everythinglearnresearchcommunity

for

Search:↓

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

High levels of androgens during early development may cause PCOS-like symptoms.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

A new model helps predict treatment success in girls with early puberty.

Polycystic ovaries are defined by having 12 or more small follicles in each ovary and are found in up to 33% of women, while Polycystic Ovary Syndrome (PCOS) is the most common hormone disorder in women of reproductive age, potentially increasing risk of obesity, diabetes, and heart diseases.

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

Female pattern hair loss is common and increases with age.

Combining cinnamon and inositol improves hormone and metabolism issues in women with PCOS.

Ayurvedic treatment, exercise, and a healthy diet can effectively manage PCOD symptoms.

Both finasteride and drospirenone effectively manage PCOS symptoms, but drospirenone is more effective in reducing ovarian volume and androgen levels.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.

Hirsute women with ovarian-sourced hirsutism are more likely to have irregular periods, with higher BMI and altered hormone ratios.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

New hair regrowth model proposed, imiquimod found to kill skin cancer cells, T-cadherin loss linked to invasive skin cancer, no clear gene link to skin cancer after transplant, and study on children's hair loss shows male dominance and genetic ties.

Society's pressure to have children later in life favors genes that increase the risk of early baldness in male offspring.

Prenatal pesticide exposure may cause earlier breast development in girls.

HDAC6 helps keep ovarian follicles dormant, extending female fertility.

IPL can cause unexpected hair growth in nearby untreated areas.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

Women with PCOS have higher renin and d-dimer levels, especially if they have COVID-19.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Genetic variants in CYP genes may worsen PCOS symptoms.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

A new hyaluronan-based biomatrix successfully supports the growth of mouse ovarian follicles, producing healthy eggs.